+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
[P.2.c.027] Healthcare cost associated with first-line antidepressant treatments in severe depression in the United Kingdom
Home
Publications
[P.2.c.027] Healthcare cost associated with first-line antidepressant treatments in severe depression in the United Kingdom
Back Home
[P.2.c.027] Healthcare cost associated with first-line antidepressant treatments in severe depression in the United Kingdom
2008 Eur Neuropsychopharmacol
Wade, A.G. | Saragoussi, D. | Despiegel, N. | Guelfucci, F. | Francois, C. |
Volume: 18, Supplement 4, Issue: , Pages: S340-0,
D,
https://www.doi.org/10.1016/S0924-977X(08)70473-5